U.S. Auto Components Stock News

If you are looking at Microchip Technology and wondering whether the current share price lines up with its underlying worth, you are not alone. The stock last closed at US$74.70, with recent returns of 16.7% over 30 days, 14.9% year to date, and 32.9% over the past year, although the 7 day return was a 0.7% decline. Recent interest around Microchip Technology has focused on how a well known semiconductor name fits into investor portfolios that are increasingly sensitive to price and quality...

FDA Breakthrough Therapy Designation: Why It Matters for Investors The latest move around Revolution Medicines (RVMD) is the FDA granting Breakthrough Therapy Designation to its RAS(ON) G12D inhibitor zoldonrasib for certain previously treated advanced non small cell lung cancer patients. See our latest analysis for Revolution Medicines. The Breakthrough Therapy news arrives after a period of sharp share price swings, with Revolution Medicines now trading at $120.28 and posting a 30 day share...

If you are wondering whether Extreme Networks is priced attractively today, the key question is whether the current US$15.96 share price still lines up with what the business is actually worth. The stock has risen 2.2% over the last 7 days, although returns over 30 days, year to date and the past year sit at 4.1%, 3.5% and 7.9% declines respectively. This may signal changing views on its potential and risks. Recent coverage of Extreme Networks has focused on how investors are reassessing...

Airbnb (ABNB) is back in focus after hiring Ahmad Al-Dahle, a former Meta generative AI leader, as Chief Technology Officer, a move investors are watching closely for its impact on AI powered travel services. See our latest analysis for Airbnb. The appointment of Ahmad Al-Dahle comes as Airbnb’s share price, at US$130.66, reflects mixed momentum, with a 7 day share price return of 6.18% and a 90 day share price return of 3.77%. The 1 year total shareholder return of 3.30% contrasts with a 5...

In recent days, LendingClub has emerged as one of the stronger performers among smaller banks after reporting improved quarterly earnings and revenue, drawing investor attention amid weakness in several large U.S. bank stocks. The company’s standing as a high-growth momentum breakout candidate, supported by upbeat analyst estimate revisions and supportive technical trends, has differentiated it from many traditional bank peers. Against this backdrop of stronger short-term earnings momentum,...

If you are wondering whether W.W. Grainger at around US$1,068.72 is priced for strength or stretched, you are not alone. This article is built to help you frame that question clearly. The stock has returned 3.8% over the last 7 days, 4.8% over the last 30 days, 6.5% year to date, but shows a 3.2% decline over the last year, while longer periods such as 3 years and 5 years sit at 96.0% and 187.0% respectively. Recent coverage of W.W. Grainger has centered on its role as a key industrial...

Why Signet Jewelers is on investors’ radar today Signet Jewelers (SIG) has drawn investor attention after recent share price moves, with the stock up 1.7% over the past day, 12.8% over the past week, and 14.3% over the past month. See our latest analysis for Signet Jewelers. The recent 1 month share price return of 14.3%, alongside a year to date share price return of 10.5%, sits against a 1 year total shareholder return of 68.4%. This suggests momentum has been stronger over the longer...

KKR (KKR) shares recently moved after a fresh look at the firm’s fundamentals, with investors weighing its recent returns, revenue and net income figures against the current share price of US$131.42. See our latest analysis for KKR. At the current share price of US$131.42, KKR’s recent 11.75% 90 day share price return contrasts with a 16.12% decline in 1 year total shareholder return. However, 3 year and 5 year total shareholder returns of 152.89% and 241.62% point to stronger longer term...

If you are trying to figure out whether Unity Software's current share price still makes sense, you are not alone. This article focuses squarely on what you are paying versus what you might be getting. The stock closed at US$40.95 and has seen a 1 year return of 88.1%, even though the last 7 days, 30 days, and year to date show returns of an 8.3% decline, 6.5% decline, and 7.5% decline respectively. Recent attention on Unity has been driven by ongoing interest in its software platform and...

In mid-January 2026, several major brokerages, including BofA Securities, Barclays, Scotiabank, and UBS, updated their views on Americold Realty Trust and the cold storage REIT segment, reshaping investor expectations for the business. The mix of cautious sector commentary alongside recognition of Americold’s expanding global temperature-controlled warehousing footprint offers a more nuanced picture of its longer-term prospects. We’ll now examine how this cluster of analyst revisions,...

BioCryst Pharmaceuticals (BCRX) recently issued full year 2026 earnings guidance, telling investors it expects total revenue between US$635 million and US$660 million, a data point that now anchors many discussions around the stock. See our latest analysis for BioCryst Pharmaceuticals. Even with the fresh 2026 revenue guidance and a slot at the J.P. Morgan Healthcare Conference, BioCryst Pharmaceuticals’ recent trading has been weak, with a 1 day share price return of 7.11% and a 7 day share...

In mid-January 2026, authID announced an integration with ServiceNow to bring secure, biometric identity verification into more than 8,400 ServiceNow-powered contact centers worldwide, including those used by most Fortune 500 companies, aiming to reduce fraud and strengthen audit trails for high-risk account changes and transactions. This move, coming alongside ServiceNow’s appointment of former Microsoft Chief Legal Officer Hossein Nowbar, underscores a broader push to reinforce trust,...

Earlier in January 2026, Littelfuse announced that Executive Vice President, Mergers & Acquisitions, Chief Legal Officer and Corporate Secretary Ryan K. Stafford will separate from the company effective April 30, 2026, while also preparing to release its fourth-quarter 2025 results on January 28, 2026. These leadership changes and upcoming earnings come as analysts highlight Littelfuse’s push into power semiconductors and EV charging infrastructure amid a broadly upbeat semiconductor...

If you are wondering whether Allstate's current share price lines up with its long term value, you are not alone. That is exactly what this article will unpack for you. After a strong multi year run, with returns of 64.1% over 3 years and 96.9% over 5 years, the stock has recently pulled back, with a 9.4% decline over 7 days, 8.0% over 30 days, and 5.7% year to date from a last close of US$192.28, while the 1 year return sits at 3.8%. Recent news flow around Allstate has focused on its...

In the past week, STERIS reported a quarterly update showing 9.9% year-on-year revenue growth, ahead of analyst expectations, alongside EBIT margin expansion to 23.1% and strong free cash flow generation. The results underscored the importance of STERIS’s recurring infection-prevention services and consumables, which, together with a sizeable healthcare capital backlog, enhanced visibility into future operating performance. Now we’ll consider how this margin expansion, driven by pricing and...

HA Sustainable Infrastructure Capital, Inc. and Sunrun Inc. recently closed a joint venture, under which HASI may invest up to US$500 million over 18 months to finance more than 300 megawatts of distributed home energy assets across over 40,000 installations nationwide. The structure allows HASI to monetize a portion of long-term customer cash flows while giving Sunrun enhanced flexibility in arranging senior project debt and retaining meaningful ownership. With this innovative joint venture...

Why Marqeta’s New CFO Matters for Investors Marqeta (MQ) has appointed Patti Kangwankij as Chief Financial Officer, effective February 9, 2026. This leadership change puts an experienced technology and payments executive at the center of its financial decision making. See our latest analysis for Marqeta. Despite the CFO appointment setting a fresh tone for execution, Marqeta’s recent 30 day share price return of 9.35% and year to date share price return of 3.88% are weaker, while the 1 year...

Why Willis Towers Watson (WTW) is on investors’ radar today Willis Towers Watson (WTW) has drawn attention after its recent share performance, with the stock last closing at US$329.41. Investors are weighing this pricing against the firm’s current earnings and growth profile. See our latest analysis for Willis Towers Watson. While the 1 day share price return of 0.28% is relatively small on its own, it sits alongside a year to date share price return of 0.96% and a 1 year total shareholder...

If you have been wondering whether Sprouts Farmers Market at around US$78.59 is still a fair deal or starting to look stretched, you are not alone. The stock has had a mixed run, with a 1.8% gain over the last 7 days, a 2.9% decline over the past month, a 2.5% decline year to date, a 43.6% return over the last year, a 151.9% return over 3 years, and a 267.1% return over 5 years. Recent coverage around Sprouts Farmers Market has focused on its positioning within the natural and organic...

Zimmer Biomet Holdings, Inc. recently disclosed that former executive officer Mark Bezjak will resign from the company and its affiliates on January 16, 2026, while CEO Ivan Tornos has outlined the company’s largest-ever direct-to-consumer campaign following multiple new orthopedic product launches. Together with management’s more cautious commentary at the J.P. Morgan Healthcare Conference, these moves highlight a period of management transition and recalibrated expectations as Zimmer...

AbCellera Biologics Inc. recently reported that it has begun dosing patients in the Phase 2 portion of its Phase 1/2 trial for ABCL635, a potential first-in-class non-hormonal treatment for moderate-to-severe menopausal vasomotor symptoms in 80 postmenopausal women. This marks the first clinical advancement from AbCellera’s GPCR and ion channel platform, highlighting how the company is moving its technology beyond discovery into internally owned therapies targeting menopause-related hot...

JetBlue Airways has recently expanded its Fort Lauderdale network with new year-round nonstop routes to Orlando and Dallas, added more daily flights to New York’s LaGuardia, and continued building out its Florida footprint with additional destinations and premium Mint offerings. This push deepens JetBlue’s role as Fort Lauderdale’s largest carrier and tightens connectivity across Florida and beyond, aligning its network more closely with leisure and visiting-friends-and-relatives travel...

BlackRock (BLK) has wrapped up FY 2025 with fourth quarter revenue of US$7.0b and basic EPS of US$7.26, while trailing 12 month figures show revenue of US$24.2b and EPS of US$35.83. Over recent periods, revenue has moved from US$20.4b in the trailing 12 months to Q4 2024 to US$24.2b by Q4 2025, with basic EPS shifting from US$42.45 to US$35.83 over the same comparison window. With trailing net profit margin at 22.9%, down from 31.2% a year earlier, the latest results pair solid top line...

Why Box Is On Investors’ Radar Today Box (BOX) is drawing attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, and year, prompting investors to reassess its current valuation. See our latest analysis for Box. Box’s recent 1 day share price return of a 2.71% decline and 7 day share price return of a 12.99% decline come on top of weaker year to date share price performance. The 5 year total shareholder return of 44.74%...